Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SRNE Sorrento Therapeutics

1.550
-0.070-4.32%
Close 09/23 16:00 ET
1.580
+0.030+1.94%
Post Mkt Price 09/23 19:55 ET
High
1.605
Open
1.570
Turnover
14.08M
Low
1.520
Pre Close
1.620
Volume
9.09M
Market Cap
697.43M
P/E(TTM)
Loss
52wk High
8.200
Shares
449.95M
P/E(Static)
Loss
52wk Low
1.150
Float Cap
662.60M
Bid/Ask %
-87.50%
Historical High
749.999
Shs Float
427.49M
Volume Ratio
1.13
Historical Low
0.500
Dividend TTM
--
Div Yield TTM
--
P/B
5.29
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.13%
Amplitude
5.25%
Avg Price
1.548
Lot Size
1
Float Cap
662.60M
Bid/Ask %
-87.50%
Historical High
749.999
Shs Float
427.49M
Volume Ratio
1.13
Historical Low
0.500
Dividend TTM
--
P/B
5.29
Dividend LFY
--
Turnover Ratio
2.13%
Amplitude
5.25%
Avg Price
1.548
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. It operates through the Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
CEO: Dr. Henry Ji,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...